» Articles » PMID: 30681346

Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes

Abstract

Background: Genetic testing for families with hypertrophic cardiomyopathy (HCM) provides a significant opportunity to improve care. Recent trends to increase gene panel sizes often mean variants in genes with questionable association are reported to patients. Classification of HCM genes and variants is critical, as misclassification can lead to genetic misdiagnosis. We show the validity of previously reported HCM genes using an established method for evaluating gene-disease associations.

Methods: A systematic approach was used to assess the validity of reported gene-disease associations, including associations with isolated HCM and syndromes including left ventricular hypertrophy. Genes were categorized as having definitive, strong, moderate, limited, or no evidence of disease causation. We also reviewed current variant classifications for HCM in ClinVar, a publicly available variant resource.

Results: Fifty-seven genes were selected for curation based on their frequent inclusion in HCM testing and prior association reports. Of 33 HCM genes, only 8 (24%) were categorized as definitive ( MYBPC3, MYH7, TNNT2, TNNI3, TPM1, ACTC1, MYL2, and MYL3); 3 had moderate evidence ( CSRP3, TNNC1, and JPH2; 33%); and 22 (66%) had limited (n=16) or no evidence (n=6). There were 12 of 24 syndromic genes definitively associated with isolated left ventricular hypertrophy. Of 4191 HCM variants in ClinVar, 31% were in genes with limited or no evidence of disease association.

Conclusions: The majority of genes previously reported as causative of HCM and commonly included in diagnostic tests have limited or no evidence of disease association. Systematically curated HCM genes are essential to guide appropriate reporting of variants and ensure the best possible outcomes for HCM families.

Citing Articles

Clinical and Genetic Heterogeneity of HCM: The Possible Role of a Deletion Involving and .

Mancuso G, Marsan M, Neroni P, Soddu C, Lai F, Serventi L Genes (Basel). 2025; 16(2).

PMID: 40004541 PMC: 11855101. DOI: 10.3390/genes16020212.


Large-scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathy.

Tadros R, Zheng S, Grace C, Jorda P, Francis C, West D Nat Genet. 2025; 57(3):530-538.

PMID: 39966646 PMC: 11906354. DOI: 10.1038/s41588-025-02087-4.


Evaluation of polygenic scores for hypertrophic cardiomyopathy in the general population and across clinical settings.

Zheng S, Jurgens S, McGurk K, Xu X, Grace C, Theotokis P Nat Genet. 2025; 57(3):563-571.

PMID: 39966645 PMC: 11906360. DOI: 10.1038/s41588-025-02094-5.


Identification of novel genetic variants associated with feline cardiomyopathy using targeted next-generation sequencing.

Raffle J, Novo Matos J, Wallace M, Wilkie L, Piercy R, Elliott P Sci Rep. 2025; 15(1):3871.

PMID: 39890868 PMC: 11785968. DOI: 10.1038/s41598-025-87852-5.


X-Chromosome-Linked miRNAs Regulate Sex Differences in Cardiac Physiology.

Emerson J, Shi W, Paredes-Larios J, Walker W, Hutton J, Cristea I Circ Res. 2025; 136(3):258-275.

PMID: 39772608 PMC: 11781965. DOI: 10.1161/CIRCRESAHA.124.325447.


References
1.
Boczek N, Ye D, Jin F, Tester D, Huseby A, Bos J . Identification and Functional Characterization of a Novel CACNA1C-Mediated Cardiac Disorder Characterized by Prolonged QT Intervals With Hypertrophic Cardiomyopathy, Congenital Heart Defects, and Sudden Cardiac Death. Circ Arrhythm Electrophysiol. 2015; 8(5):1122-32. PMC: 5094060. DOI: 10.1161/CIRCEP.115.002745. View

2.
Grant A, Cushman B, Cave H, Dillon M, Gelb B, Gripp K . Assessing the gene-disease association of 19 genes with the RASopathies using the ClinGen gene curation framework. Hum Mutat. 2018; 39(11):1485-1493. PMC: 6326381. DOI: 10.1002/humu.23624. View

3.
Girolami F, Iascone M, Tomberli B, Bardi S, Benelli M, Marseglia G . Novel α-actinin 2 variant associated with familial hypertrophic cardiomyopathy and juvenile atrial arrhythmias: a massively parallel sequencing study. Circ Cardiovasc Genet. 2014; 7(6):741-50. DOI: 10.1161/CIRCGENETICS.113.000486. View

4.
Walsh R, Thomson K, Ware J, Funke B, Woodley J, McGuire K . Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med. 2016; 19(2):192-203. PMC: 5116235. DOI: 10.1038/gim.2016.90. View

5.
Jarcho J, McKenna W, Pare J, Solomon S, Holcombe R, Dickie S . Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1. N Engl J Med. 1989; 321(20):1372-8. DOI: 10.1056/NEJM198911163212005. View